LSBPW

LakeShore Biopharma Co., Ltd Warrants

18 hedge funds and large institutions have $381K invested in LakeShore Biopharma Co., Ltd Warrants in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.

Holders
18
Holders Change
-3
Holders Change %
-14.29%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
Reduced
1
Closed
3
Calls
$40K
Puts
Net Calls
+$40K
Net Calls Change
-$35K
Name Market Value Shares Shares
Change
Shares
Change %
LP
1
LMR Partners
United Kingdom
$83.6K 1,052,461 +1,052,461 New
VAM
2
Valliance Asset Management
Hong Kong
$59.6K 750,000
FC
3
Finepoint Capital
Massachusetts
$48.5K 489,999
AC
4
Athos Capital
Hong Kong
$45K 128,981
Jane Street
5
Jane Street
New York
$39.6K 498,301
BCL
6
Bracebridge Capital LLC
Massachusetts
$18.4K 232,323
OCM
7
Ovata Capital Management
Hong Kong
$14.9K 150,000
Calamos Advisors
8
Calamos Advisors
Illinois
$14.5K 146,040
QGA
9
Q Global Advisors
Texas
$10K 130,600
WA
10
Whitebox Advisors
Minnesota
$9.93K 125,000
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$9.9K 100,000
SCM
12
Saba Capital Management
New York
$7.73K 97,299
Walleye Capital
13
Walleye Capital
New York
$7.55K 95,030 -4,875 -5%
CF
14
Cantor Fitzgerald
New York
$6.15K 76,931
CS
15
Clear Street
New York
$3.83K 48,168
SIA
16
SkyView Investment Advisors
New Jersey
$1K 12,210
AA
17
Ancora Advisors
Ohio
$401 5,050
HIM
18
HGC Investment Management
Ontario, Canada
$397 5,000
CAC
19
Cowen and Company
New York
-212,849 Closed
MC
20
Meteora Capital
Florida
-25,000 Closed
TSS
21
Two Sigma Securities
New York
-17,400 Closed
CFGS
22
Concourse Financial Group Securities
Alabama
Millennium Management
23
Millennium Management
New York
HCM
24
Highbridge Capital Management
New York
Deutsche Bank
25
Deutsche Bank
Germany